Candel Therapeutics IncNASDAQ:CADL
- LAST PRICE6.0500
- TODAY'S CHANGE (%)0.1400 (2.3689%)
- Bid / Lots5.9700/ 3
- Ask / Lots6.1200/ 5
- Open / Previous Close6.0400 / 5.9100
- Day Range
- 52 Week Range
- Volume672,175
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CADL |
|---|---|---|
| 09:32 ET | 10736 | 6.0999 |
| 09:34 ET | 8969 | 6.0816 |
| 09:36 ET | 11032 | 6.125 |
| 09:38 ET | 4634 | 6.19 |
| 09:39 ET | 12911 | 6.1309 |
| 09:41 ET | 13190 | 6.1923 |
| 09:43 ET | 28976 | 6.25 |
| 09:45 ET | 9238 | 6.26 |
| 09:48 ET | 5017 | 6.225 |
| 09:50 ET | 44279 | 6.1 |
| 09:52 ET | 1954 | 6.1 |
| 09:54 ET | 1000 | 6.17 |
| 09:56 ET | 1472 | 6.1301 |
| 09:57 ET | 13745 | 6.1 |
| 09:59 ET | 5748 | 6.12 |
| 10:01 ET | 1919 | 6.15 |
| 10:03 ET | 1681 | 6.18 |
| 10:06 ET | 1330 | 6.1999 |
| 10:08 ET | 502 | 6.2 |
| 10:10 ET | 300 | 6.13 |
| 10:12 ET | 2000 | 6.135 |
| 10:14 ET | 2183 | 6.08 |
| 10:15 ET | 4837 | 6.1329 |
| 10:17 ET | 100 | 6.1028 |
| 10:19 ET | 21369 | 6.01 |
| 10:21 ET | 100 | 6.065 |
| 10:24 ET | 11800 | 6.05 |
| 10:26 ET | 6688 | 6.05 |
| 10:28 ET | 666 | 6.03 |
| 10:30 ET | 33161 | 5.87 |
| 10:32 ET | 8539 | 5.86 |
| 10:33 ET | 7322 | 5.88 |
| 10:35 ET | 5266 | 5.8739 |
| 10:37 ET | 2137 | 5.87 |
| 10:39 ET | 5693 | 5.8099 |
| 10:42 ET | 4906 | 5.795 |
| 10:44 ET | 3114 | 5.81 |
| 10:46 ET | 7956 | 5.7201 |
| 10:48 ET | 800 | 5.76 |
| 10:50 ET | 20518 | 5.7601 |
| 10:51 ET | 2796 | 5.79 |
| 10:53 ET | 11427 | 5.83 |
| 10:55 ET | 2247 | 5.9226 |
| 10:57 ET | 6040 | 5.95 |
| 11:00 ET | 29297 | 5.86 |
| 11:04 ET | 15673 | 5.9 |
| 11:06 ET | 2656 | 5.89 |
| 11:08 ET | 171 | 5.9 |
| 11:09 ET | 600 | 5.88 |
| 11:11 ET | 3003 | 5.845 |
| 11:15 ET | 200 | 5.88 |
| 11:18 ET | 100 | 5.89 |
| 11:20 ET | 1260 | 5.89 |
| 11:22 ET | 100 | 5.89 |
| 11:24 ET | 859 | 5.89 |
| 11:26 ET | 1950 | 5.8501 |
| 11:29 ET | 1200 | 5.83 |
| 11:31 ET | 1447 | 5.86 |
| 11:33 ET | 2300 | 5.89 |
| 11:38 ET | 200 | 5.89 |
| 11:40 ET | 100 | 5.9179 |
| 11:42 ET | 725 | 5.92 |
| 11:44 ET | 1300 | 5.93 |
| 11:45 ET | 343 | 5.95 |
| 11:47 ET | 3629 | 5.86 |
| 11:49 ET | 600 | 5.873 |
| 11:54 ET | 3249 | 5.86 |
| 11:58 ET | 2000 | 5.85 |
| 12:02 ET | 1088 | 5.8501 |
| 12:03 ET | 635 | 5.9 |
| 12:09 ET | 200 | 5.86 |
| 12:12 ET | 165 | 5.8621 |
| 12:16 ET | 500 | 5.873 |
| 12:18 ET | 800 | 5.8979 |
| 12:20 ET | 300 | 5.9 |
| 12:21 ET | 100 | 5.91 |
| 12:23 ET | 2157 | 5.87 |
| 12:25 ET | 3189 | 5.8506 |
| 12:27 ET | 1066 | 5.8558 |
| 12:32 ET | 100 | 5.84 |
| 12:36 ET | 1270 | 5.83 |
| 12:38 ET | 1150 | 5.89 |
| 12:41 ET | 100 | 5.94 |
| 12:43 ET | 1500 | 5.95 |
| 12:48 ET | 13300 | 6.0357 |
| 12:50 ET | 10518 | 6.0999 |
| 12:52 ET | 2188 | 6.1 |
| 12:54 ET | 100 | 6.06 |
| 12:56 ET | 100 | 6.1 |
| 12:57 ET | 2100 | 6.1 |
| 12:59 ET | 350 | 6.08 |
| 01:01 ET | 300 | 6.12 |
| 01:06 ET | 900 | 6.12 |
| 01:08 ET | 808 | 6.1101 |
| 01:10 ET | 2496 | 6.105 |
| 01:12 ET | 200 | 6.08 |
| 01:19 ET | 100 | 6.095 |
| 01:24 ET | 500 | 6.05 |
| 01:26 ET | 200 | 6.04 |
| 01:28 ET | 4345 | 6.09 |
| 01:30 ET | 2300 | 6.07 |
| 01:32 ET | 2714 | 6.09 |
| 01:33 ET | 445 | 6.13 |
| 01:35 ET | 3768 | 6.13 |
| 01:37 ET | 2100 | 6.1276 |
| 01:39 ET | 1103 | 6.12 |
| 01:42 ET | 2366 | 6.1287 |
| 01:44 ET | 900 | 6.175 |
| 01:46 ET | 1398 | 6.1899 |
| 01:48 ET | 100 | 6.1675 |
| 01:50 ET | 1095 | 6.085 |
| 01:57 ET | 3398 | 6.03 |
| 02:04 ET | 1450 | 6 |
| 02:06 ET | 100 | 6 |
| 02:08 ET | 12347 | 5.91 |
| 02:09 ET | 200 | 5.93 |
| 02:11 ET | 1700 | 5.9 |
| 02:13 ET | 600 | 5.92 |
| 02:15 ET | 1700 | 5.885 |
| 02:20 ET | 500 | 5.8899 |
| 02:24 ET | 10002 | 5.9482 |
| 02:27 ET | 100 | 5.95 |
| 02:29 ET | 10071 | 5.95 |
| 02:31 ET | 100 | 6 |
| 02:36 ET | 2299 | 6 |
| 02:38 ET | 100 | 6.015 |
| 02:40 ET | 557 | 5.985 |
| 02:42 ET | 100 | 5.9925 |
| 02:44 ET | 1785 | 5.97 |
| 02:45 ET | 1100 | 6.02 |
| 02:49 ET | 1600 | 6.07 |
| 02:51 ET | 300 | 6.05 |
| 02:54 ET | 700 | 6 |
| 02:56 ET | 200 | 6.03 |
| 02:58 ET | 950 | 6.03 |
| 03:00 ET | 1200 | 5.97 |
| 03:02 ET | 367 | 6.01 |
| 03:03 ET | 1300 | 5.98 |
| 03:05 ET | 343 | 6.01 |
| 03:07 ET | 800 | 6.01 |
| 03:09 ET | 100 | 5.99 |
| 03:12 ET | 200 | 6.005 |
| 03:14 ET | 400 | 6.01 |
| 03:16 ET | 400 | 6.017 |
| 03:18 ET | 1472 | 6.02 |
| 03:20 ET | 6579 | 6.03 |
| 03:21 ET | 100 | 6.04 |
| 03:23 ET | 507 | 6.0399 |
| 03:25 ET | 2282 | 6.02 |
| 03:30 ET | 700 | 6.04 |
| 03:32 ET | 2600 | 6.07 |
| 03:34 ET | 100 | 6.07 |
| 03:36 ET | 3165 | 6.0989 |
| 03:38 ET | 1559 | 6.06 |
| 03:41 ET | 1600 | 6.085 |
| 03:43 ET | 100 | 6.08 |
| 03:45 ET | 500 | 6.11 |
| 03:48 ET | 5606 | 6.08 |
| 03:50 ET | 7318 | 6.07 |
| 03:52 ET | 4011 | 6.06 |
| 03:54 ET | 3286 | 6.06 |
| 03:56 ET | 881 | 6.06 |
| 03:57 ET | 3267 | 6.01 |
| 03:59 ET | 4890 | 6.05 |
Apr 11, 2024
DJ Candel Therapeutics Shares Leap Premarket on FDA Orphan-Drug Designation, from 9:15AM ET on Thursday Apr 11, 2024 by Dow Jones
9:15AM ET on Thursday Apr 11, 2024 by Dow JonesCandel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer, from 9:00AM ET on Thursday Apr 11, 2024 by Dow Jones
9:00AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 9, 2024
Apr 4, 2024
DJ Candel Therapeutics Shares Hit 52-Week High After Positive Trial Data, from 12:31PM ET on Thursday Apr 04, 2024 by Dow Jones
12:31PM ET on Thursday Apr 04, 2024 by Dow JonesCandel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer, from 8:00AM ET on Thursday Apr 04, 2024 by Dow Jones
8:00AM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Candel Therapeutics Inc | 173.4M | -4.6x | --- |
Adicet Bio Inc | 172.5M | -0.6x | --- |
Kodiak Sciences Inc | 174.9M | -0.7x | --- |
Greenwich Lifesciences Inc | 169.2M | -18.2x | --- |
Omeros Corp | 179.0M | -1.1x | --- |
Gossamer Bio Inc | 166.4M | -0.5x | --- |
Company Information
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Contact Information
- Headquarters
- 117 Kendrick Street,, Suite 450NEEDHAM, MA, United States 02494
- Phone
- 617-916-5445
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Manning
- President, Chief Executive Officer, Director
- Paul Tak
- Interim Chief Financial Officer
- Charles Schoch
- Chief Scientific Officer
- Francesca Barone
- Vice President - Development Leader
- Christopher Matheny
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $173.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.31 |
Book Value | $0.44 |
P/E Ratio | -4.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
